Skip to search boxSkip to navigationSkip to main content

Sulfated glucuronyl glycolipids and gangliosides in the optic nerve of humans

  • H. Yoshino
    ,
  • Y. Maeda
    ,
  • M. King
    ,
  • M. J. Cartwright
    ,
  • D. W. Richards
    ,
  • T. Ariga
*Corresponding author for this work
  • Virginia Commonwealth University
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Pathologically delayed visual evoked potentials may be present in patients with neuropathy associated with IgM M-proteinemia, which is directed against myelin-associated glycoprotein and sulfated glucuronyl glycolipids (SGGLs), but there are no reports of these antigens in the optic nerve. We recently examined human optic nerve and occipital lobe tissues for the occurrence of SGGLs using the technique of immunostaining on thin-layer chromatographic plates and found them in the optic nerve, but not the occipital lobe. SGGLs in the optic nerve may represent target antigens for CNS involvement by the M-protein in patients with neuropathy. We also studied the ganglioside composition of the optic nerve and found it different from that of the brain. Human optic nerve is characterized by an abundance of the b-series gangliosides, including GD1b, GT1b, and GQ1b. GD1a, which is usually a major component of brain gangliosides, is only a minor species of the optic nerve ganglioside fraction.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 408-411 (4 pages)

Journal (Volume, Issue Number)

Neurology (Volume 43, Issue 2)

Publication milestones

  • Published - 02/1993

Publication status

Published - 02/1993

ISSN

0028-3878

Publication IDs

  • Scopus: 0027512307
  • PubMed: 8437709

Publication metrics

Metrics

Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1
Scopus
citations

PlumX

Citation count
32
Captures
5

Funding Details

FunderFunding number
NINDS
R01NS026994